Delivery included to the United States

Authorized Generic Drugs

Authorized Generic Drugs Short and Long-Term Competitive Effects - Pharmacology Research, Safety Testing, and Regulation.

Hardback (13 Nov 2012)

Save $67.00

  • RRP $351.36
  • $284.36
Add to basket

Includes delivery to the United States

3 copies available online - Usually dispatched within 7 days

Publisher's Synopsis

Rising health care costs have for many years focused congressional attention upon the development and availability of prescription drugs. Recently, the presence of "authorised generic" pharmaceuticals in the drug marketplace has been the subject of congressional concern. An "authorised generic" is a pharmaceutical that is marketed by or on behalf of a brand-named drug company, but is sold under a generic name. The brand-name firm may distribute the drug under its own auspices or via a license to a generic drug company. The price of this "authorised copy" is ordinarily lower than that of the brand-name drug. Some sources refer to authorised generics as "branded," "flanking," or "pseudo" generics." This book presents an analysis of the innovation and public health issues relating to authorised generic drugs beginning with a review of the procedures through which independent generic drug companies receive government permission to market their products and resolve patent disputes with brand-name firms and consumer welfare.

About the Publisher

Nova Science Publishers

NOVA publishes a wide array of books and journals from authors around the globe.

Book information

ISBN: 9781622570751
Publisher: Nova Science Publishers Inc
Imprint: Nova Science Publishers
Pub date:
Language: English
Number of pages: 216
Weight: 556g
Height: 183mm
Width: 261mm
Spine width: 17mm